1-Deoxynojirimycin

Preferred Label : 1-Deoxynojirimycin;

MeSH definition : An alpha-glucosidase inhibitor with antiviral action. Derivatives of deoxynojirimycin may have anti-HIV activity.;

MeSH synonym : 1 deoxynojirimycin;

MeSH hyponym : moranoline; bay n 5595; 1-Deoxynojirimycin hydrochloride; 1 Deoxynojirimycin Hydrochloride;

Related MeSH term : 1,5-Dideoxy-1,5-imino-D-mannitol; 1-Deoxymannojirimycin; 1,5-Deoxy-1,5-imino-D-mannitol; 1 Deoxymannojirimycin;

MeSH CAS label : 3,4,5-Piperidinetriol, 2-(hydroxymethyl)-, (2R-(2alpha,3beta,4alpha,5beta))-;

MeSH Related Number : 1,5-Dideoxy-1,5-imino-D-mannitol; 1-Deoxynojirimycin hydrochloride; 73285-50-4 (HCl); 84444-90-6 (1,5-dideoxy-1,5-imino-D-mannitol);

Registry Number MeSH : 19130-96-2;

Related CAS MeSH : 84444-90-6 (1,5-Dideoxy-1,5-imino-D-mannitol); 73285-50-4 (1-Deoxynojirimycin hydrochloride);

Wikipedia link : https://en.wikipedia.org/wiki/1-Deoxynojirimycin;

Is substance : O;

Details

Origin ID

D017485;

UMLS CUI

C0089267;

Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analogs and derivatives [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Currated CISMeF NLP mapping
- Duvoglustat [NCIt concept]
- Duvoglustat (substance) [SNOMED CT concept]
Pharmacological action(s)
- antiviral agents [MeSH Descriptor]
- enzyme inhibitors [MeSH Descriptor]
Record concept(s)
- 1,5-Deoxy-1,5-imino-D-mannitol [MeSH concept]
- 1,5-Dideoxy-1,5-imino-D-mannitol [MeSH concept]
- 1-Deoxymannojirimycin [MeSH concept]
- 1-Deoxynojirimycin [MeSH concept]
- 1-Deoxynojirimycin hydrochloride [MeSH concept]
- bay n 5595 [MeSH concept]
- moranoline [MeSH concept]
Related MeSH Supplementary Concept(s)
- 1,4,6-trideoxy-4,4-difluoronojirimycin [MeSH Supplementary Concept]
- 1,6-dideoxynojirimycin [MeSH Supplementary Concept]
- 1-deoxy-3-O-(5-thioglucopyranosyl)mannojirimycin [MeSH Supplementary Concept]
- 1-deoxy-3-S-(1-thioglucopyranosyl)mannojirimycin [MeSH Supplementary Concept]
- 1-deoxy-5-dehydroxymethyl-nojirimycin [MeSH Supplementary Concept]
- 1-deoxy-D-galactohomonojirimycin [MeSH Supplementary Concept]
- 1-deoxy-gulonojirimycin [MeSH Supplementary Concept]
- 1-deoxy-talonojirimycin [MeSH Supplementary Concept]
- 1-deoxyallonojirimycin [MeSH Supplementary Concept]
- 1-deoxythionojirimycin [MeSH Supplementary Concept]
- 2,5-imino-2,5-dideoxyfucitol [MeSH Supplementary Concept]
- 2-acetamido-1,2-dideoxy-D-galacto-nojirimycin [MeSH Supplementary Concept]
- 2-acetamido-1,2-dideoxy-D-gluco-nojirimycin [MeSH Supplementary Concept]
- 2-acetamido-1,2-dideoxyallonojirimycin [MeSH Supplementary Concept]
- 2-acetamido-1,5-imino-1,2,5-trideoxy-D-glucitol [MeSH Supplementary Concept]
- 3-O-galactopyranoylmoranoline [MeSH Supplementary Concept]
- 4-O-galactopyranosylmoranoline [MeSH Supplementary Concept]
- 4-O-glucopyranosylmoranoline [MeSH Supplementary Concept]
- 5-N,6-O-(N''-octyliminomethylidene)nojirimycin [MeSH Supplementary Concept]
- 5-N,6-S-(N''-4'-(adamantane-1-carbonylamino)butyliminomethylidene)-6-thionojirimycin [MeSH Supplementary Concept]
- 5N,6S-(N'-butyliminomethylidene)-6-thio-1-deoxygalactonojirimycin [MeSH Supplementary Concept]
- 6-amino-6-deoxy-5,6-di-N-(N'-octyliminomethylidene)nojirimycin [MeSH Supplementary Concept]
- 6-deoxymannojirimycin [MeSH Supplementary Concept]
- 6-thio-(5N,6S)-(4-(N'-dansylamino)butyliminomethylidene)nojirimycin [MeSH Supplementary Concept]
- D-allo-1-deoxynojirimycin [MeSH Supplementary Concept]
- D-galacto-1-deoxynojirimycin [MeSH Supplementary Concept]
- DLHex-DGJ [MeSH Supplementary Concept]
- L-1-deoxyallonojirimycin [MeSH Supplementary Concept]
- L-1-deoxymannojirimycin [MeSH Supplementary Concept]
- L-altro-1-deoxynojirimycin [MeSH Supplementary Concept]
- L-deoxyidonojirimycin [MeSH Supplementary Concept]
- N,N-dimethyldeoxynojirimycin [MeSH Supplementary Concept]
- N-(2-fluorophenyl)-2beta-1-deoxyfuconojirimycin acetamide [MeSH Supplementary Concept]
- N-(3'-iodo-2'-propenyl)-1-deoxynojirimycin [MeSH Supplementary Concept]
- N-(3'-iodobenzyl)-1-deoxynojirimycin [MeSH Supplementary Concept]
- N-(3-phenyl-2-propenyl)-1-deoxynojirimycin [MeSH Supplementary Concept]
- N-(5'-carboxypentyl)-1-deoxynojirimycin [MeSH Supplementary Concept]
- N-(5-adamantane-1-yl-methoxy-pentyl)deoxynojirimycin [MeSH Supplementary Concept]
- N-(8-(3-ethynylphenoxy)octyl)-1-deoxynojirimycin [MeSH Supplementary Concept]
- N-9-methoxynonyldeoxynojirimycin [MeSH Supplementary Concept]
- N-benzyl-1-deoxynojirimycin [MeSH Supplementary Concept]
- N-methyl-1-deoxynojirimycin-6-phosphate [MeSH Supplementary Concept]
- N-methyldeoxynojirimycin [MeSH Supplementary Concept]
- N-methylhomonojirimycin [MeSH Supplementary Concept]
- N-nonyl-1-deoxynojirimycin [MeSH Supplementary Concept]
- N-pentafluorobenzyl-1-deoxynojirimycin [MeSH Supplementary Concept]
- N-pentyl-1-deoxynojirimycin [MeSH Supplementary Concept]
- N-stearoyl-1-deoxynojirimycin [MeSH Supplementary Concept]
- deoxyfuconojirimycin [MeSH Supplementary Concept]
- deoxynojirimycine [MeSH Supplementary Concept]
- emiglitate [MeSH Supplementary Concept]
- fuconojirimycin [MeSH Supplementary Concept]
- glucopyranosyl-(1-3-)-1-deoxymannojirimycin [MeSH Supplementary Concept]
- homomannojirimycin [MeSH Supplementary Concept]
- homonojirimycin [MeSH Supplementary Concept]
- l-ido-1-deoxynojirimycin [MeSH Supplementary Concept]
- migalastat [MeSH Supplementary Concept]
- miglitol [MeSH Supplementary Concept]
- miglustat [MeSH Supplementary Concept]
- nojirimycin [MeSH Supplementary Concept]
- nojirimycin 6-phosphate [MeSH Supplementary Concept]
- nojirimycin tetrazole [MeSH Supplementary Concept]
- quinazoline-1-deoxynojirimycin [MeSH Supplementary Concept]
- rhamno-1-deoxynojirimycin [MeSH Supplementary Concept]
- ureido-N-hexyl deoxynojirimycin [MeSH Supplementary Concept]
See also inter- (CISMeF)
- Product containing duvoglustat (medicinal product) [SNOMED CT concept]
Semantic type(s)
- Organic Chemical [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- Duvoglustat [NCIt concept]
- Duvoglustat (substance) [SNOMED CT concept]
- Product containing duvoglustat (medicinal product) [SNOMED CT concept]
Validated automatic mappings to BTNT
- Duvoglustat hydrochloride (substance) [SNOMED CT concept]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients